Lortab and Electrocardiogram abnormal - a phase IV clinical study of FDA data


Electrocardiogram abnormal is found among people who take Lortab, especially for people who are female, 50-59 old.

The phase IV clinical study analyzes which people take Lortab and have Electrocardiogram abnormal. It is created by eHealthMe based on reports of 29,018 people who have side effects when taking Lortab from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On Aug, 09, 2022

29,018 people reported to have side effects when taking Lortab.
Among them, 40 people (0.14%) have Electrocardiogram abnormal.

What is Lortab?

Lortab has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 28,970 Lortab users for its effectiveness, alternative drugs and more.

What is Electrocardiogram abnormal?

Electrocardiogram abnormal is found to be associated with 1,394 drugs and 890 conditions by eHealthMe.

Number of Lortab and Electrocardiogram abnormal reports submitted per year:

Could Lortab cause Electrocardiogram abnormal?

Gender of people who have Electrocardiogram abnormal when taking Lortab *:

  • female: 65 %
  • male: 35 %

Age of people who have Electrocardiogram abnormal when taking Lortab *:

  • 0-1: 3.03 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 9.09 %
  • 50-59: 63.64 %
  • 60+: 24.24 %

Common drugs people take besides Lortab *:

  1. Coumadin: 22 people, 55.00%
  2. Lasix: 21 people, 52.50%
  3. Aspirin: 20 people, 50.00%
  4. Digoxin: 14 people, 35.00%
  5. Naproxen: 13 people, 32.50%
  6. Lisinopril: 13 people, 32.50%
  7. Oxycontin: 13 people, 32.50%
  8. Prinivil: 13 people, 32.50%
  9. Prilosec: 12 people, 30.00%
  10. Femara: 12 people, 30.00%

Common side effects people have besides Electrocardiogram abnormal *:

  1. Heart Attack: 24 people, 60.00%
  2. Fatigue (feeling of tiredness): 22 people, 55.00%
  3. Nausea (feeling of having an urge to vomit): 20 people, 50.00%
  4. Anaemia (lack of blood): 19 people, 47.50%
  5. Joint Pain: 19 people, 47.50%
  6. Fall: 18 people, 45.00%
  7. Urinary Tract Infection: 16 people, 40.00%
  8. Constipation: 16 people, 40.00%
  9. Sinusitis (inflammation of sinus): 16 people, 40.00%
  10. Nausea And Vomiting: 16 people, 40.00%

Common conditions people have *:

  1. Metastases To Bone (cancer spreads to bone): 12 people, 30.00%
  2. Breast Cancer: 12 people, 30.00%
  3. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 5 people, 12.50%
  4. Cardiac Failure Congestive: 4 people, 10.00%
  5. Depression: 3 people, 7.50%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 7.50%
  7. Type 2 Diabetes: 2 people, 5.00%
  8. Anaemia (lack of blood): 2 people, 5.00%
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 5.00%
  10. Asthma: 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lortab and have Electrocardiogram abnormal?

Check whether Electrocardiogram abnormal is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of Lortab:

Electrocardiogram abnormal treatments and more:

COVID vaccines that are related to Electrocardiogram abnormal:

How severe was Electrocardiogram abnormal and when was it recovered:

Expand to all the drugs that have ingredients of acetaminophen; hydrocodone bitartrate:

Common drugs associated with Electrocardiogram abnormal:

All the drugs that are associated with Electrocardiogram abnormal:

Common conditions associated with Electrocardiogram abnormal:

All the conditions that are associated with Electrocardiogram abnormal:

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; hydrocodone bitartrate (the active ingredients of Lortab) and Lortab (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: